Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Burden of atopic dermatitis in Asia.

Tsai TF, Rajagopalan M, Chu CY, Encarnacion L, Gerber RA, Santos-Estrella P, Llamado LJQ, Tallman AM.

J Dermatol. 2019 Oct;46(10):825-834. doi: 10.1111/1346-8138.15048. Epub 2019 Aug 22. Review.

PMID:
31436343
2.

Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel.

Schaller M, Almeida LMC, Bewley A, Cribier B, Del Rosso J, Dlova NC, Gallo RL, Granstein RD, Kautz G, Mannis MJ, Micali G, Oon HH, Rajagopalan M, Steinhoff M, Tanghetti E, Thiboutot D, Troielli P, Webster G, Zierhut M, van Zuuren EJ, Tan J.

Br J Dermatol. 2019 Aug 7. doi: 10.1111/bjd.18420. [Epub ahead of print]

PMID:
31392722
3.

Guidelines on Management of Atopic Dermatitis in India: An Evidence-Based Review and an Expert Consensus.

Rajagopalan M, De A, Godse K, Krupa Shankar DS, Zawar V, Sharma N, Mukherjee S, Sarda A, Dhar S.

Indian J Dermatol. 2019 May-Jun;64(3):166-181. doi: 10.4103/ijd.IJD_683_18.

4.

Two-component kinase TrcS complements Mycobacterium smegmatis mtrB kinase mutant.

Sarva K, Satsangi AT, Plocinska R, Madiraju M, Rajagopalan M.

Tuberculosis (Edinb). 2019 May;116S:S107-S113. doi: 10.1016/j.tube.2019.04.017. Epub 2019 May 3.

PMID:
31088763
5.

MtrA Response Regulator Controls Cell Division and Cell Wall Metabolism and Affects Susceptibility of Mycobacteria to the First Line Antituberculosis Drugs.

Gorla P, Plocinska R, Sarva K, Satsangi AT, Pandeeti E, Donnelly R, Dziadek J, Rajagopalan M, Madiraju MV.

Front Microbiol. 2018 Nov 23;9:2839. doi: 10.3389/fmicb.2018.02839. eCollection 2018.

6.

Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India).

Rajagopalan M, Inamadar A, Mittal A, Miskeen AK, Srinivas CR, Sardana K, Godse K, Patel K, Rengasamy M, Rudramurthy S, Dogra S.

BMC Dermatol. 2018 Jul 24;18(1):6. doi: 10.1186/s12895-018-0073-1.

7.

Anomalous mechanical behavior of nanocrystalline binary alloys under extreme conditions.

Turnage SA, Rajagopalan M, Darling KA, Garg P, Kale C, Bazehhour BG, Adlakha I, Hornbuckle BC, Williams CL, Peralta P, Solanki KN.

Nat Commun. 2018 Jul 12;9(1):2699. doi: 10.1038/s41467-018-05027-5.

8.

Molecular dynamics study of TMPA mediated dissociation of Nur77-LKB1 complex.

Rungsung I, Rajagopalan M, Ramaswamy A.

Comput Biol Chem. 2018 Oct;76:67-78. doi: 10.1016/j.compbiolchem.2018.06.002. Epub 2018 Jun 30.

PMID:
29982165
9.

Patient perceptions of clear/almost clear skin in moderate-to-severe plaque psoriasis: results of the Clear About Psoriasis worldwide survey.

Armstrong A, Jarvis S, Boehncke WH, Rajagopalan M, Fernández-Peñas P, Romiti R, Bewley A, Vaid B, Huneault L, Fox T, Sodha M, Warren RB.

J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2200-2207. doi: 10.1111/jdv.15065. Epub 2018 Jul 31.

PMID:
29730888
10.

Prevalence and Burden Related to Genital Warts in India.

Khopkar US, Rajagopalan M, Chauhan AR, Kothari-Talwar S, Singhal PK, Yee K, Kulkarni A, Lara N, Roset M, Giuliano AR, Garland SM.

Viral Immunol. 2018 Jun;31(5):346-351. doi: 10.1089/vim.2017.0157. Epub 2018 May 2.

PMID:
29717924
11.

Drug Reaction with Eosinophilia and Systemic Symptoms: An Update and Review of Recent Literature.

De A, Rajagopalan M, Sarda A, Das S, Biswas P.

Indian J Dermatol. 2018 Jan-Feb;63(1):30-40. doi: 10.4103/ijd.IJD_582_17.

12.

Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update.

Godse K, De A, Zawar V, Shah B, Girdhar M, Rajagopalan M, Krupashankar DS.

Indian J Dermatol. 2018 Jan-Feb;63(1):2-15. doi: 10.4103/ijd.IJD_308_17. Review.

13.

A Case of Cutaneous T-cell Lymphoma, Masquerading as Psoriasis, Was Given Etanercept and Secukinumab: Emphasizing the Need for Biopsy Confirmation before Starting Biologics.

De A, Raychaudhury T, Rajagopalan M, Sarda A, Sharma N.

Indian J Dermatol. 2017 Sep-Oct;62(5):533-535. doi: 10.4103/ijd.IJD_311_17. No abstract available.

14.

Insights into the RNA binding mechanism of human L1-ORF1p: a molecular dynamics study.

Rajagopalan M, Balasubramanian S, Ramaswamy A.

Mol Biosyst. 2017 Aug 22;13(9):1728-1743. doi: 10.1039/c7mb00358g.

PMID:
28714502
15.

Structural dynamics of wild type and mutated forms of human L1 endonuclease and insights into its sequence specific nucleic acid binding mechanism: A molecular dynamics study.

Rajagopalan M, Balasubramanian S, Ramaswamy A.

J Mol Graph Model. 2017 Sep;76:43-55. doi: 10.1016/j.jmgm.2017.07.002. Epub 2017 Jul 5.

PMID:
28704776
16.

Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice.

Cohen AD, Wu JJ, Puig L, Chimenti S, Vender R, Rajagopalan M, Romiti R, de la Cruz C, Skov L, Zachariae C, Young HS, Foley P, van der Walt JM, Naldi L, Prens EP, Blauvelt A.

Br J Dermatol. 2017 Dec;177(6):1495-1502. doi: 10.1111/bjd.15756. Epub 2017 Nov 27. Review.

PMID:
28646580
17.

Cost-effectiveness Analysis of Stereotactic Radiosurgery Alone Versus Stereotactic Radiosurgery with Upfront Whole Brain Radiation Therapy for Brain Metastases.

Kim H, Rajagopalan MS, Beriwal S, Smith KJ.

Clin Oncol (R Coll Radiol). 2017 Oct;29(10):e157-e164. doi: 10.1016/j.clon.2017.05.001. Epub 2017 May 26.

PMID:
28552517
18.

Diagnosis and Management of Chronic Pruritus: An Expert Consensus Review.

Rajagopalan M, Saraswat A, Godse K, Shankar DS, Kandhari S, Shenoi SD, Tahiliani S, Zawar VV.

Indian J Dermatol. 2017 Jan-Feb;62(1):7-17. doi: 10.4103/0019-5154.198036. Review.

19.

Design and Synthesis of Novel, Selective GPR40 AgoPAMs.

Plummer CW, Clements MJ, Chen H, Rajagopalan M, Josien H, Hagmann WK, Miller M, Trujillo ME, Kirkland M, Kosinski D, Mane J, Pachanski M, Cheewatrakoolpong B, Nolting AF, Orr R, Christensen M, Campeau LC, Wright MJ, Bugianesi R, Souza S, Zhang X, Di Salvo J, Weinglass AB, Tschirret-Guth R, Nargund R, Howard AD, Colletti SL.

ACS Med Chem Lett. 2017 Jan 23;8(2):221-226. doi: 10.1021/acsmedchemlett.6b00443. eCollection 2017 Feb 9.

20.

Biologics use in Indian psoriasis patients.

Rajagopalan M, Mital A.

Indian Dermatol Online J. 2016 Nov-Dec;7(6):489-497.

21.

Structural dynamics of nucleosome mediated by acetylations at H3K56 and H3K115,122.

Rajagopalan M, Balasubramanian S, Ioshikhes I, Ramaswamy A.

Eur Biophys J. 2017 Jul;46(5):471-484. doi: 10.1007/s00249-016-1191-5. Epub 2016 Dec 8.

PMID:
27933430
22.

Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel.

Schaller M, Almeida LM, Bewley A, Cribier B, Dlova NC, Kautz G, Mannis M, Oon HH, Rajagopalan M, Steinhoff M, Thiboutot D, Troielli P, Webster G, Wu Y, van Zuuren E, Tan J.

Br J Dermatol. 2017 Feb;176(2):465-471. doi: 10.1111/bjd.15173. Epub 2017 Feb 5.

PMID:
27861741
23.

The conformational feasibility for the formation of reaching dimer in ASV and HIV integrase: a molecular dynamics study.

Balasubramanian S, Rajagopalan M, Bojja RS, Skalka AM, Andrake MD, Ramaswamy A.

J Biomol Struct Dyn. 2017 Dec;35(16):3469-3485. doi: 10.1080/07391102.2016.1257955. Epub 2016 Nov 28.

24.

Screening and Development of New Inhibitors of FtsZ from M. Tuberculosis.

Mathew B, Hobrath JV, Ross L, Connelly MC, Lofton H, Rajagopalan M, Guy RK, Reynolds RC.

PLoS One. 2016 Oct 21;11(10):e0164100. doi: 10.1371/journal.pone.0164100. eCollection 2016.

25.

Modulation of human T cell cytokines by the Mycobacterium tuberculosis-secreted protein Wag31.

Samten B, Fannin S, Sarva K, Yi N, Madiraju M, Rajagopalan M.

Tuberculosis (Edinb). 2016 Dec;101S:S99-S104. doi: 10.1016/j.tube.2016.09.017. Epub 2016 Sep 28.

PMID:
27742462
26.

Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel.

Tan J, Almeida LM, Bewley A, Cribier B, Dlova NC, Gallo R, Kautz G, Mannis M, Oon HH, Rajagopalan M, Steinhoff M, Thiboutot D, Troielli P, Webster G, Wu Y, van Zuuren EJ, Schaller M.

Br J Dermatol. 2017 Feb;176(2):431-438. doi: 10.1111/bjd.15122. Epub 2017 Jan 23.

PMID:
27718519
27.

Biosimilars for psoriasis: clinical studies to determine similarity.

Blauvelt A, Puig L, Chimenti S, Vender R, Rajagopalan M, Romiti R, Skov L, Zachariae C, Young H, Prens E, Cohen A, van der Walt J, Wu JJ.

Br J Dermatol. 2017 Jul;177(1):23-33. doi: 10.1111/bjd.15067. Epub 2017 May 28. Review.

PMID:
27639072
28.

Extreme creep resistance in a microstructurally stable nanocrystalline alloy.

Darling KA, Rajagopalan M, Komarasamy M, Bhatia MA, Hornbuckle BC, Mishra RS, Solanki KN.

Nature. 2016 Sep 15;537(7620):378-81. doi: 10.1038/nature19313.

PMID:
27629642
29.

Substituted 4-morpholine N-arylsulfonamides as γ-secretase inhibitors.

Zhao Z, Pissarnitski DA, Josien HB, Bara TA, Clader JW, Li H, McBriar MD, Rajagopalan M, Xu R, Terracina G, Hyde L, Song L, Zhang L, Parker EM, Osterman R, Buevich AV.

Eur J Med Chem. 2016 Nov 29;124:36-48. doi: 10.1016/j.ejmech.2016.08.024. Epub 2016 Aug 13.

PMID:
27560281
30.

Correlation of diffusion tensor imaging parameters with neural status in Pott's spine.

Jain N, Saini NS, Kumar S, Rajagopalan M, Chakraborti KL, Jain AK.

SICOT J. 2016 Apr 29;2:21. doi: 10.1051/sicotj/2016014.

31.

Position statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patients.

Godse K, Rajagopalan M, Girdhar M, Kandhari S, Shah B, Chhajed PN, Tahiliani S, Shankar DS, Somani V, Zawar V.

Indian Dermatol Online J. 2016 Jan-Feb;7(1):6-11. doi: 10.4103/2229-5178.174314. Review.

32.

Cytomegalovirus infection inducing flare of Behcet's disease with possible recurrence of glomerulonephritis after renal transplantation.

Annigeri RA, Rajagopalan M, Mani RM, Kaveripattu SS.

Indian J Nephrol. 2016 Jan-Feb;26(1):45-8. doi: 10.4103/0971-4065.157418.

33.

Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a Protease Inhibitor.

Neelamkavil SF, Agrawal S, Bara T, Bennett C, Bhat S, Biswas D, Brockunier L, Buist N, Burnette D, Cartwright M, Chackalamannil S, Chase R, Chelliah M, Chen A, Clasby M, Colandrea VJ, Davies IW, Eagen K, Guo Z, Han Y, Howe J, Jayne C, Josien H, Kargman S, Marcantonio K, Miao S, Miller R, Nolting A, Pinto P, Rajagopalan M, Ruck RT, Shah U, Soriano A, Sperbeck D, Velazquez F, Wu J, Xia Y, Venkatraman S.

ACS Med Chem Lett. 2015 Dec 22;7(1):111-6. doi: 10.1021/acsmedchemlett.5b00425. eCollection 2016 Jan 14.

34.

Clinical Pathways: A Catalyst for the Adoption of Hypofractionation for Early-Stage Breast Cancer.

Chapman BV, Rajagopalan MS, Heron DE, Flickinger JC, Beriwal S.

Int J Radiat Oncol Biol Phys. 2015 Nov 15;93(4):854-61. doi: 10.1016/j.ijrobp.2015.08.013. Epub 2015 Aug 7.

PMID:
26530754
35.

Impact of dynamic changes to a bone metastases pathway in a large, integrated, National Cancer Institute-designated comprehensive cancer center network.

Gebhardt BJ, Rajagopalan MS, Gill BS, Heron DE, Rakfal SM, Flickinger JC, Beriwal S.

Pract Radiat Oncol. 2015 Nov-Dec;5(6):398-405. doi: 10.1016/j.prro.2015.06.013. Epub 2015 Jul 4.

PMID:
26432676
36.

Mycobacterium tuberculosis oriC sequestration by MtrA response regulator.

Purushotham G, Sarva KB, Blaszczyk E, Rajagopalan M, Madiraju MV.

Mol Microbiol. 2015 Oct;98(3):586-604. doi: 10.1111/mmi.13144. Epub 2015 Aug 31.

37.

RNase HI Is Essential for Survival of Mycobacterium smegmatis.

Minias AE, Brzostek AM, Korycka-Machala M, Dziadek B, Minias P, Rajagopalan M, Madiraju M, Dziadek J.

PLoS One. 2015 May 12;10(5):e0126260. doi: 10.1371/journal.pone.0126260. eCollection 2015.

38.

Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis.

Gill BS, Bernard ME, Lin JF, Balasubramani GK, Rajagopalan MS, Sukumvanich P, Krivak TC, Olawaiye AB, Kelley JL, Beriwal S.

Gynecol Oncol. 2015 Jun;137(3):365-72. doi: 10.1016/j.ygyno.2015.03.056. Epub 2015 Apr 11.

PMID:
25868965
39.

Changing practice patterns for breast cancer radiation therapy with clinical pathways: An analysis of hypofractionation in a large, integrated cancer center network.

Rajagopalan MS, Flickinger JC, Heron DE, Beriwal S.

Pract Radiat Oncol. 2015 Mar-Apr;5(2):63-9. doi: 10.1016/j.prro.2014.10.004.

PMID:
25748004
40.

Iminopyrimidinones: a novel pharmacophore for the development of orally active renin inhibitors.

McKittrick BA, Caldwell JP, Bara T, Boykow G, Chintala M, Clader J, Czarniecki M, Courneya B, Duffy R, Fleming L, Giessert R, Greenlee WJ, Heap C, Hong L, Huang Y, Iserloh U, Josien H, Khan T, Korfmacher W, Liang X, Mazzola R, Mitra S, Moore K, Orth P, Rajagopalan M, Roy S, Sakwa S, Strickland C, Vaccaro H, Voigt J, Wang H, Wong J, Zhang R, Zych A.

Bioorg Med Chem Lett. 2015 Apr 1;25(7):1592-6. doi: 10.1016/j.bmcl.2015.02.003. Epub 2015 Feb 10.

PMID:
25728416
41.

Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation of vertebral bone metastases.

Kim H, Rajagopalan MS, Beriwal S, Huq MS, Smith KJ.

Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):556-63. doi: 10.1016/j.ijrobp.2014.10.055. Epub 2015 Jan 30.

PMID:
25680599
42.

Patterns of care for omission of radiation therapy for elderly women with early-stage breast cancer receiving hormonal therapy.

Rhieu BH, Rajagopalan MS, Sukumvanich P, Kelley JL, Ahrendt GM, Heron DE, Beriwal S.

Pract Radiat Oncol. 2015 Jul-Aug;5(4):e267-73. doi: 10.1016/j.prro.2014.12.003. Epub 2015 Jan 22.

PMID:
25620165
43.

The midgut of the silkmoth Bombyx mori is able to recycle molecules derived from degeneration of the larval midgut epithelium.

Franzetti E, Romanelli D, Caccia S, Cappellozza S, Congiu T, Rajagopalan M, Grimaldi A, de Eguileor M, Casartelli M, Tettamanti G.

Cell Tissue Res. 2015 Aug;361(2):509-28. doi: 10.1007/s00441-014-2081-8. Epub 2015 Jan 8.

PMID:
25563842
44.

Structure of CrgA, a cell division structural and regulatory protein from Mycobacterium tuberculosis, in lipid bilayers.

Das N, Dai J, Hung I, Rajagopalan MR, Zhou HX, Cross TA.

Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):E119-26. doi: 10.1073/pnas.1415908112. Epub 2014 Dec 29. Erratum in: Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):E816. Rajagopalan, Malini R [corrected to Rajagopalan, Malini R].

45.

Quantitative evaluation of radiation oncologists' adaptability to lower reimbursing treatment programs.

Gill BS, Beriwal S, Rajagopalan MS, Wang H, Hodges K, Greenberger JS.

Pract Radiat Oncol. 2015 Jul-Aug;5(4):267-73. doi: 10.1016/j.prro.2014.10.014. Epub 2014 Nov 5.

PMID:
25544552
46.

In regard to Olson et al and Ellsworth et al.

Rajagopalan MS, Beriwal S, Heron DE.

Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1258. doi: 10.1016/j.ijrobp.2014.07.040. No abstract available.

PMID:
25539376
47.

Extended field intensity modulated radiation therapy for gynecologic cancers: Is the risk of duodenal toxicity high?

Xu KM, Rajagopalan MS, Kim H, Beriwal S.

Pract Radiat Oncol. 2015 Jul-Aug;5(4):e291-7. doi: 10.1016/j.prro.2014.10.013. Epub 2014 Nov 5.

PMID:
25532491
48.

Cost-effectiveness analysis of 3D image-guided brachytherapy compared with 2D brachytherapy in the treatment of locally advanced cervical cancer.

Kim H, Rajagopalan MS, Beriwal S, Huq MS, Smith KJ.

Brachytherapy. 2015 Jan-Feb;14(1):29-36. doi: 10.1016/j.brachy.2014.09.002. Epub 2014 Oct 16.

PMID:
25443528
49.

Patterns of care and brachytherapy boost utilization for vaginal cancer in the United States.

Rajagopalan MS, Xu KM, Lin J, Hansen K, Sukumvanich P, Krivak TC, Kelley JL, Beriwal S.

Pract Radiat Oncol. 2015 Jan-Feb;5(1):56-61. doi: 10.1016/j.prro.2014.03.004. Epub 2014 Apr 22.

PMID:
25413431
50.

Calmodulin-like protein from M. tuberculosis H37Rv is required during infection.

Advani MJ, Rajagopalan M, Reddy PH.

Sci Rep. 2014 Oct 31;4:6861. doi: 10.1038/srep06861.

Supplemental Content

Loading ...
Support Center